ChemImage, a biotech firm, is embroiled in a federal court trial against Johnson & Johnson over a multibillion-dollar contract signed in 2019 for surgical robotics. The lawsuit, stemming from alleged breaches of contract, seeks $1.5 billion in damages, with a potential settlement of $180 million if ChemImage prevails. The firm claims J&J's withdrawal from the partnership devastated its operations and prevented the development of critical AI imaging technology that could improve surgical results. The trial is overseen by US District Judge Jesse Furman, who has limited the damages ChemImage may pursue.
Johnson & Johnson executives are set to testify in a trial over a $1.5 billion breach of contract lawsuit filed by ChemImage, a former partner.
ChemImage, having partnered with J&J for surgical robotics, accused the healthcare giant of breaking promises that led to its downfall.
Collection
[
|
...
]